Tag: Prescription Drugs
Many Drugs Made Available Via FDA Expanded Access Programs
Half of meds ID'd in expanded access programs treat cancer; others for metabolic, endocrine diseases
Dexmedetomidine Cuts γ-Aminobutyric Acid Receptor Function
Cuts etomidate-induced increase in α5 γ-aminobutyric acid type A receptor cell-surface expression
Diabetes Meds Reconciliation May Reduce Risk of ER Visits
Medication reconciliation linked to lower risk of combined ER visits, hospitalization over six months
Meds With Depression As Adverse Side Effect Commonly Used
Prevalence of depression higher for adults reporting use of multiple meds with depression as side effect
Topical Rapamycin Effective for TSC-Related Facial Angiofibromas
One percent rapamycin seems most effective for tuberous sclerosis complex-linked angiofibromas
Mifepristone Pre-Tx Improves Management of Early Miscarriage
Successful management likely for pretreatment with mifepristone followed by misoprostol
FDA: Opioid Antidote Naloxone Recalled
Two lots of Naloxone recalled due to potential presence of particulate matter in syringe plunger
ASCO: Pembrolizumab Superior for Initial Tx of Advanced NSCLC
Improved overall survival versus chemotherapy regardless of the PD-L1 tumor proportion score
ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer
Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival
Oral Propranolol Seems Safe for Infantile Hemangioma
Good safety profile for children with infantile hemangioma with no prespecified underlying disease
